These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Mini review: animal model of human lysosomal storage disease]. Sakiyama T Nihon Rinsho; 1995 Dec; 53(12):3105-11. PubMed ID: 8577067 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for the lysosomal storage disorders. Cabrera-Salazar MA; Novelli E; Barranger JA Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873 [TBL] [Abstract][Full Text] [Related]
5. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis. Grabowski GA Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334 [TBL] [Abstract][Full Text] [Related]
6. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse. Virta S; Rapola J; Jalanko A; Laine M J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders. Cheng SH; Smith AE Gene Ther; 2003 Aug; 10(16):1275-81. PubMed ID: 12883523 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation and gene therapy for lysosomal storage diseases. Hoogerbrugge PM; Valerio D Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S34-6. PubMed ID: 9630322 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches. Haskins M Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S25-7. PubMed ID: 8971403 [TBL] [Abstract][Full Text] [Related]